Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

Sponsors and Collaborators
M.D. Anderson Cancer Center
GlaxoSmithKline

Contact
Nizar M. Tannir, MD
713-792-2830

Principal Investigator
Nizar M. Tannir, MD
UT MD Anderson Cancer Center

ClinicalTrials.gov Identifier
NCT01392183